Online citations, reference lists, and bibliographies.
Please confirm you are human
(Sign Up for free to never see this)
← Back to Search

Preparation And Characterization Of Furosemide Nanosuspensions

T. Gulsun, Sahand E. Borna, Sahand E. Borna, İmran Vural, Selma Şahin
Published 2018 · Materials Science

Save to my Library
Download PDF
Analyze on Scholarcy
Share
Abstract Furosemide, a widely used loop diuretic, has a low aqueous solubility, and low permeability. Nanosuspensions have been widely used to increase the solubility of poorly soluble drugs. The aim of this study was to develop and characterize furosemide containing nanosuspensions. Furosemide nanosuspensions with Tween 80, were prepared using high pressure homogenization method using ultrasonic probe or ultra turrax, ball milling method, and combination of these methods. The physicochemical properties of furosemide, physical mixture and nanosuspensions were evaluated by FT-IR, DSC and X-ray analyses. Particle size, polydispersity index, zeta potential, solubility and permeability of nanosuspensions were also determined. FT-IR analysis revealed that characteristic peaks of furosemide were seen in all formulations. X-ray analysis indicated that crystalline structure of furosemide was preserved in nanosuspensions. The particle size of furosemide decreased significantly (p
This paper references
10.4314/TJPR.V8I1.14711
Formulation and Evaluation of Solid Dispersions of Furosemide in Sodium Starch Glycolate
G. Chaulang (2009)
10.4103/0975-7406.84459
Development and characterization of nanosuspensions of olmesartan medoxomil for bioavailability enhancement
H. Thakkar (2011)
10.1016/J.IJPHARM.2005.10.003
A pilot study of freeze drying of poly(epsilon-caprolactone) nanocapsules stabilized by poly(vinyl alcohol): formulation and process optimization.
W. Abdelwahed (2006)
Preparation and Characterization of Solid Dispersion Tablet of Furosemide with Crospovidone
G. Chaulang (2008)
10.1007/978-1-60327-198-1_6
Zeta potential measurement.
Jeffrey D. Clogston (2011)
10.1002/JPS.1127
Effect of common excipients on Caco-2 transport of low-permeability drugs.
B. Rege (2001)
10.1002/WICS.1310
Bioavailability and Bioequivalence in Drug Development.
S. Chow (2014)
10.1002/jps.24505
Few Drugs Display Flip-Flop Pharmacokinetics and These Are Primarily Associated with Classes 3 and 4 of the BDDCS.
Kimberly L Garrison (2015)
10.1248/CPB.C16-00049
Formulation of Nanoparticle Containing Everolimus Using Microfluidization and Freeze-Drying.
Su Hyun Seok (2016)
SYNTHESIS AND CHARACTERIZATION OF FUROSEMIDE COMPLEX IN β-CYCLODEXTRIN
A. Farcas (2006)
10.1691/ph.2017.6149
Preparation and evaluation of furosemide containing orally disintegrating tablets by direct compression.
T. Gulsun (2017)
10.1007/s11095-007-9523-x
The Use of BDDCS in Classifying the Permeability of Marketed Drugs
L. Benet (2007)
10.1007/s11051-014-2360-z
Formulation, optimization, and in vitro/in vivo evaluation of furosemide nanosuspension for enhancement of its oral bioavailability
B. Sahu (2014)
10.1016/j.addr.2011.02.001
Physical and chemical stability of drug nanoparticles.
L. Wu (2011)
10.1080/21691401.2017.1358732
Improved oral bioavailability for lutein by nanocrystal technology: formulation development, in vitro and in vivo evaluation
Daoxiao Chang (2018)
10.1016/J.EJPB.2005.09.005
Spray coated pellets as carrier system for mucoadhesive drug nanocrystals.
J. Möschwitzer (2006)
10.1016/j.apsb.2014.06.013
Transmission FTIR derivative spectroscopy for estimation of furosemide in raw material and tablet dosage form
M. Gallignani (2014)
10.1016/j.ijpharm.2008.07.023
Top-down production of drug nanocrystals: nanosuspension stabilization, miniaturization and transformation into solid products.
B. Van Eerdenbrugh (2008)
10.1023/A:1012102522787
In Vitro Permeability Across Caco-2 Cells (Colonic) Can Predict In Vivo (Small Intestinal) Absorption in Man—Fact or Myth
Shiyin Yee (2004)
10.1007/s13346-016-0292-0
Nanocrystal for ocular drug delivery: hope or hype
O. P. Sharma (2016)
Nanoprecipitation with sonication for enhancement of oral bioavailability of furosemide.
B. Sahu (2014)
10.1002/jps.22030
Biowaiver monographs for immediate release solid oral dosage forms: furosemide.
G. Granero (2010)
Overview of factors affecting oral drug absorption
Naining Song (2004)
10.15272/AJBPS.V2I13.113
Novel techniques for solubility, dissolution rate and bioavailability enhancement of class II and IV drugs
R. PawarAnil (2012)
10.1016/j.ijpharm.2011.03.050
Nanosuspensions of poorly soluble drugs: preparation and development by wet milling.
Peng Liu (2011)
Sulfacetamide loaded Eudragit® RL100 nanosuspension with potential for ocular delivery.
B. Mandal (2010)
10.1016/j.ijpharm.2011.11.025
Comparison of different methods for preparation of a stable riccardin D formulation via nano-technology.
G. Liu (2012)
10.1248/CPB.48.646
Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
K. Kimura (2000)
10.1208/pt070233
Role of surfactant and pH on dissolution properties of fenofibrate and glipizide—A technical note
Shahla Jamzad (2008)
10.1016/J.IJPHARM.2007.05.039
Effect of pH on the solubility and release of furosemide from polyamidoamine (PAMAM) dendrimer complexes.
B. Devarakonda (2007)
10.1021/JS980111K
Link between drug absorption solubility and permeability measurements in Caco-2 cells.
V. Pade (1998)
10.1016/J.EJPB.2005.05.009
Drug nanocrystals of poorly soluble drugs produced by high pressure homogenisation.
C. Keck (2006)
10.1023/A:1016212804288
A Theoretical Basis for a Biopharmaceutic Drug Classification: The Correlation of in Vitro Drug Product Dissolution and in Vivo Bioavailability
G. Amidon (2004)
10.1016/S0928-0987(00)00076-2
Optimized conditions for prediction of intestinal drug permeability using Caco-2 cells.
S. Yamashita (2000)
10.1016/S0169-409X(00)00118-6
Nanosuspensions as particulate drug formulations in therapy. Rationale for development and what we can expect for the future.
R. Mueller (2001)
10.3109/03639045.2012.699067
Preparation, characterization, stability and in vitro-in vivo evaluation of pellet-layered Simvastatin nanosuspensions
Yanfei Luo (2013)
10.1002/JPS.20075
Combined application of parallel artificial membrane permeability assay and Caco-2 permeability assays in drug discovery.
E. Kerns (2004)
10.3109/1061186X.2011.645161
A mini review of nanosuspensions development
Y. Liu (2012)
10.3797/scipharm.0912-23
Liquisolid Systems to Improve the Dissolution of Furosemide
B. Akinlade (2010)
10.1016/j.ejpb.2017.05.008
Novel strategies for the formulation and processing of poorly water‐soluble drugs
K. Göke (2018)
10.1208/s12249-017-0801-6
Exploration of alginates as potential stabilizers of nanosuspension
J. Guan (2017)
10.1002/jps.22587
Nanonization of itraconazole by high pressure homogenization: stabilizer optimization and effect of particle size on oral absorption.
Wei Sun (2011)
10.1016/j.ijpharm.2011.02.051
Nanosuspension for improving the bioavailability of a poorly soluble drug and screening of stabilizing agents to inhibit crystal growth.
Indrajit K. Ghosh (2011)
10.18433/J3PW2W
Investigation of nanosized crystalline form to improve the oral bioavailability of poorly water soluble cilostazol.
Xiaoqing Miao (2011)



This paper is referenced by
10.2147/IJN.S265659
Nose-to-Brain Delivery by Nanosuspensions-Based in situ Gel for Breviscapine
Yingchong Chen (2020)
10.1208/s12249-020-01653-9
Development of Nanocrystal Ziprasidone Orally Disintegrating Tablets: Optimization by Using Design of Experiment and In Vitro Evaluation
Emine Taşhan (2020)
10.35333/jrp.2020.115
Design of cefaclor monohydrate containing nanoparticles with extended antibacterial effect by Nano-Spray dryer: A Nanoenglobing study
A. A. Öztürk (2020)
10.1016/J.JDDST.2019.01.034
Preparation, optimization of intravenous ZL-004 nanosuspensions by the precipitation method, effect of particle size on in vivo pharmacokinetics and tissue distribution
Chengyue Guo (2019)
10.1016/j.molliq.2020.114924
Vicissitudes of liquid crystals for solubility enhancement of poorly soluble drugs
A. Shoaib (2021)
10.1016/j.jddst.2020.101927
Clotrimazole nanosuspensions-loaded hyaluronic acid-catechol/polyvinyl alcohol mucoadhesive films for oral candidiasis treatment
Chaiyakarn Pornpitchanarong (2020)
10.1007/s11095-020-02815-x
Investigation of Formulation and Process Parameters of Wet Media Milling to Develop Etodolac Nanosuspensions
A. Karakucuk (2020)
10.1007/s12393-019-09208-w
Nanoscale Delivery System for Nutraceuticals: Preparation, Application, Characterization, Safety, and Future Trends
J. Chen (2019)
10.35333/jrp.2019.65
Optimization and evaluation of cyclosporine A nanosuspension stabilized by combination stabilizers using high pressure homogenization method
Sıla Gülbağ Pinar (2019)
10.4274/tjps.galenos.2020.67366
In Vitro Caco-2 Cell Permeability Studies of Ziprasidone Hydrochloride Monohydrate Nanocrystals
A. Karakucuk (2020)
10.3390/pharmaceutics12010080
Oral Treatment of Spontaneously Hypertensive Rats with Captopril-Surface Functionalized Furosemide-Loaded Multi-Wall Lipid-Core Nanocapsules
Cecilia B Michalowski (2020)
10.1016/j.ejps.2019.02.021
Enhanced dissolution/caco‐2 permeability, pharmacokinetic and pharmacodynamic performance of re‐dispersible eprosartan mesylate nanopowder
Prachi B. Shekhawat (2019)
10.1016/j.ejps.2020.105597
Development and Characterization of Pullulan-based Orally Disintegrating Films Containing Amlodipine Besylate.
Esra Pezik (2020)
10.3390/PR7080520
Evaluation of Oleic Acid and Polyethylene Glycol Monomethyl Ether Conjugate (PEGylated Oleic Acid) as a Solubility Enhancer of Furosemide
Rahul S. Kalhapure (2019)
10.1016/J.JDDST.2018.10.035
Preparation of solid lipid nanoparticles of furosemide-silver complex and evaluation of antibacterial activity
P. Bolla (2019)
10.1016/j.jddst.2020.101638
The role of stabilizers and mechanical processes on physico-chemical and anti-inflammatory properties of methotrexate nanosuspensions
A. M. D. Santos (2020)
10.1007/s00216-020-02845-9
An improved drop casting electrochemical strategy for furosemide quantification in natural waters exploiting chemically reduced graphene oxide on glassy carbon electrodes
Sancler C. Vasconcelos (2020)
Semantic Scholar Logo Some data provided by SemanticScholar